Scientific References – Publications
QPS Neuropharmacology
QPS encourages its scientists to publish and disseminate the results of their high quality research which is mostly done in close collaboration with our clients.
The following articles are hyperlinked to the original journal article or an abstract of the article:
Found 75 Results
Page 2 of 8
Page 2 of 8
Page 2 of 8
Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s Disease.
October 10, 2017
SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer’s disease.
September 13, 2017
Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.
July 12, 2017
Quantitative evaluation of orofacial motor function in mice: The pasta gnawing test, a voluntary and stress-free behavior test.
December 1, 2016
Brain cortical cholesterol metabolism is highly affected by human APP overexpression in mice.
July 7, 2016
Decreased Plasma Aβ in Hyperlipidemic APPSL Transgenic Mice is Associated with BBB Dysfunction.
June 1, 2016
Late-stage α-synuclein accumulation in TNWT-61 mouse model of Parkinson’s disease detected by diffusion kurtosis imaging.
December 19, 2015
Page 2 of 8
